Skip to main content
Journal ArticleOPEN ACCESS

Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer

Cochrane Database of Systematic Reviews (2020) 2020(5)
DOI: 10.1002/14651858.CD013605
1Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the benefits and harms of anti-angiogenesis agents for the treatment of metastatic and recurrent cervical cancer.

Cite

CITATION STYLE

APA

Rizzuto, I., Otter, S. J., Bharathan, R., & Stewart, A. (2020). Vascular endothelial growth factor (VEGF) inhibitors for the treatment of metastatic and recurrent cervical cancer. Cochrane Database of Systematic Reviews, 2020(5). https://doi.org/10.1002/14651858.CD013605

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free